Skip to Main Content

Try STAT+ TODAY

cholesterol

Most Read

Biotech By Jonathan Wosen

Guardant accuses Illumina of ‘brazen’ attempt to quash competition in ongoing legal battle

The Readout LOUD By Adam Feuerstein and Meg Tirrell

Listen: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

CDC_MONKEYPOX

Pharmalot By Ed Silverman

As monkeypox spreads, Bavarian Nordic’s CEO is fielding calls for his vaccine, but doesn’t see panic

Health Insurance Claim Form

D.C. Diagnosis By Rachel Cohrs

California senators advance three bills meant to crack down on health insurers

Noubar Afeyan

Biotech By Ryan Cross — The Boston Globe

Flagship’s latest startup launches with bold claim: the discovery of thousands of new human proteins

Pharmalot By Ed Silverman

Pharmalittle: Teva and Allergan reach $161 million opioid settlement with West Virginia; FDA lifts hold on Bharat Covid shot

Wyden & Crapo

Politics By Rachel Cohrs

Key Senate panel wants to axe in-person requirement for virtual mental health services

Opinions+ By Emily Johnson and Jenna Phillips

QR codes can help pharmaceutical companies in two big ways

All Coverage

Pfizer

Pharmalot By Ed Silverman

Pfizer stops developing a cholesterol drug. So who is the big winner?

Clogged Artery

Health By Damian Garde

Raising ‘good’ cholesterol doesn’t protect against heart disease after all, study finds

advertisement

Cholesterol Drugs

Biotech By Damian Garde

These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating

Baby boy fertility treatments

Health By Associated Press

Testing cholesterol in toddlers and babies? Study says it could help

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective

AstraZeneca signage

Pharmalot By Ed Silverman

AstraZeneca sues FDA to prevent generic versions of Crestor

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Are too many companies chasing the same kind of cancer drug?

Pharmalot By Ed Silverman

Sanofi revamps top management, chief diabetes exec to leave

Watchdogs -- 5 Year Watch

The Watchdogs By Ivan Oransky and Adam Marcus

Why a drug that lowers cholesterol doesn’t save lives

Pharmalot By Ed Silverman

Aegerion to pay $40M and plead guilty to illegally marketing cholesterol drug

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Cigna to get discounts if cholesterol meds don’t work

Pharmalot By Ed Silverman

What generics? Americans spent an extra $73b for brand-name meds

Cholesterol blood test

First Opinion By Patrick Skerrett

New guidelines simplify cholesterol tests: no fasting needed

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Little company makes big bet on discarded Roche drug

Pharmalot By Ed Silverman

Docs won’t prescribe pricey new cholesterol meds unless they lower heart risks

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Docs puzzle over cholesterol drug results

Health By Associated Press

Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure

Sanofi

Pharmalot By Ed Silverman

Why one analyst thinks a Sanofi and Regeneron cholesterol drug will be yanked

Cholesterol

In the Lab By Elie Dolgin

Jewish grandma’s DNA points to new ways of treating heart disease

DNA

In the Lab By Eric Boodman

‘Essential’ genes may not be so essential after all

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: setback for Merck, Valeant to offer discounts at Walgreens

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: US drug prices are highest, UnitedHealth favors Regeneron

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: CVS covers new cholesterol drug, FDA Duchenne hearing

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: cholesterol fighter rejected, antibiotics survey

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Merck, PBMs, and lung cancer drug